Drug Research

Finland-based Forendo Pharma has announced it has signed a licensing and collaboration agreement with Novartis. The research collaboration will focus on discovering and developing HSD17B (17-beta-hydroxysteroid dehydregonase) inhibitors, which is a family of enzymes that regulates hormone action in specific...

MedPharm, the leader in topical and transdermal drug delivery, has moved into its newly expanded facility in Durham, North Carolina. The $4M expansion has tripled the facility’s footprint to approximately 25,000 sq. ft, significantly expanding capacity and supporting MedPharm’s continued...

Twist Bioscience Corporation, a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, announced an expanded antibody optimization collaboration with Pandion Therapeutics. Based on the successful completion of its first project for...

PCI Pharma Services (PCI), a leading pharmaceutical and biopharmaceutical global outsourcing solutions provider, announced it has begun an expansion of its Tredegar facility in Wales, UK to enhance its high potent drug manufacturing and development capabilities, including both clinical...

Abzena is showcasing its new Developability Service, enabling biotechnology and pharmaceutical companies to improve lead selection and de-risk cell line development, at Antibody Engineering & Therapeutics 2019 being held 9–13 December, on Booth #414 at the Marriott Marquis San...

China’s National Healthcare Security Administration (NHSA) has announced it has agreed an average 61% cut in prices of 70 top-selling drugs with large pharma manufacturers in exchange for inclusion on a state-run insurance scheme list. According to the South China...

The US Food and Drug Administration (FDA) has granted tentative approval for Aleor Dermaceuticals’ Diclofenac sodium topical solution USP, 2% w / w to treat the pain of osteoarthritis of the knees. Aleor is a 60:40 joint venture (JV) between...